nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMS—lung cancer	0.315	1	CbGaD
Floxuridine—TYMS—Pemetrexed—lung cancer	0.244	0.654	CbGbCtD
Floxuridine—Decitabine—Gemcitabine—lung cancer	0.166	1	CrCrCtD
Floxuridine—TYMS—Gemcitabine—lung cancer	0.088	0.235	CbGbCtD
Floxuridine—TYMS—Methotrexate—lung cancer	0.0415	0.111	CbGbCtD
Floxuridine—TYMP—mammary gland—lung cancer	0.00238	0.165	CbGeAlD
Floxuridine—TYMP—respiratory system—lung cancer	0.00159	0.11	CbGeAlD
Floxuridine—TYMS—respiratory system—lung cancer	0.00136	0.0946	CbGeAlD
Floxuridine—TYMP—bronchus—lung cancer	0.00131	0.0907	CbGeAlD
Floxuridine—TYMP—trachea—lung cancer	0.00117	0.0815	CbGeAlD
Floxuridine—TYMP—Fluoropyrimidine Activity—ABCG2—lung cancer	0.00115	0.0278	CbGpPWpGaD
Floxuridine—TYMS—bronchus—lung cancer	0.00112	0.0779	CbGeAlD
Floxuridine—TYMP—cardiac atrium—lung cancer	0.0011	0.0765	CbGeAlD
Floxuridine—TYMP—Fluoropyrimidine Activity—CYP2A6—lung cancer	0.00108	0.0261	CbGpPWpGaD
Floxuridine—TYMP—bone marrow—lung cancer	0.000931	0.0646	CbGeAlD
Floxuridine—TYMP—Pyrimidine metabolism—TYMS—lung cancer	0.000912	0.022	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—SMUG1—lung cancer	0.000883	0.0213	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—RRM1—lung cancer	0.000851	0.0205	CbGpPWpGaD
Floxuridine—TYMP—lung—lung cancer	0.000844	0.0585	CbGeAlD
Floxuridine—TYMP—Nucleotide metabolism—RRM1—lung cancer	0.000836	0.0201	CbGpPWpGaD
Floxuridine—TYMS—bone marrow—lung cancer	0.000799	0.0554	CbGeAlD
Floxuridine—TYMS—lung—lung cancer	0.000724	0.0502	CbGeAlD
Floxuridine—TYMS—Fluoropyrimidine Activity—ABCC3—lung cancer	0.000724	0.0174	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TYMS—lung cancer	0.000707	0.017	CbGpPWpGaD
Floxuridine—Zidovudine—TERT—lung cancer	0.000696	0.297	CrCbGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—ERCC2—lung cancer	0.000657	0.0158	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MMP1—lung cancer	0.000625	0.015	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—ABCG2—lung cancer	0.00059	0.0142	CbGpPWpGaD
Floxuridine—TYMP—lymph node—lung cancer	0.000577	0.04	CbGeAlD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—PPP2R1B—lung cancer	0.000575	0.0139	CbGpPWpGaD
Floxuridine—TYMS—Trans-sulfuration and one carbon metabolism—GCLC—lung cancer	0.000569	0.0137	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—CYP2A6—lung cancer	0.000555	0.0134	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—EGF—lung cancer	0.000539	0.013	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—HMGB2—lung cancer	0.000517	0.0125	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—BRAF—lung cancer	0.000513	0.0124	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—RB1—lung cancer	0.000504	0.0121	CbGpPWpGaD
Floxuridine—Cladribine—RRM1—lung cancer	0.000503	0.215	CrCbGaD
Floxuridine—TYMP—Bladder Cancer—CDH1—lung cancer	0.000502	0.0121	CbGpPWpGaD
Floxuridine—TYMS—lymph node—lung cancer	0.000495	0.0344	CbGeAlD
Floxuridine—TYMP—Bladder Cancer—MAP2K1—lung cancer	0.000483	0.0116	CbGpPWpGaD
Floxuridine—Trifluridine—TYMS—lung cancer	0.000472	0.202	CrCbGaD
Floxuridine—TYMS—Docetaxel—Paclitaxel—lung cancer	0.000466	0.185	CbGdCrCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—SMUG1—lung cancer	0.000452	0.0109	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—RRM1—lung cancer	0.000451	0.0109	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—MCL1—lung cancer	0.000451	0.0109	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—lung cancer	0.000443	0.0107	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MDM2—lung cancer	0.00043	0.0104	CbGpPWpGaD
Floxuridine—TYMS—Nucleotide metabolism—RRM1—lung cancer	0.000428	0.0103	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—ERBB2—lung cancer	0.000424	0.0102	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CXCL8—lung cancer	0.000402	0.00968	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RRM1—lung cancer	0.000392	0.00944	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CCND1—lung cancer	0.000374	0.00902	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—CAT—lung cancer	0.000372	0.00896	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—XRCC1—lung cancer	0.000368	0.00886	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—CDKN1A—lung cancer	0.000362	0.00872	CbGpPWpGaD
Floxuridine—TYMP—Nucleotide metabolism—TYMS—lung cancer	0.000355	0.00856	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MSH6—lung cancer	0.000349	0.00842	CbGpPWpGaD
Floxuridine—TYMS—Erlotinib—Gefitinib—lung cancer	0.000348	0.138	CbGdCrCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—ERCC2—lung cancer	0.000336	0.0081	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—VEGFA—lung cancer	0.000326	0.00786	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—MYC—lung cancer	0.0003	0.00723	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—EGFR—lung cancer	0.000294	0.00707	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—KMT2A—lung cancer	0.000265	0.00638	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000252	0.00608	CbGpPWpGaD
Floxuridine—TYMS—Podofilox—Teniposide—lung cancer	0.000251	0.0995	CbGdCrCtD
Floxuridine—TYMP—Bladder Cancer—TP53—lung cancer	0.000247	0.00594	CbGpPWpGaD
Floxuridine—TYMS—E2F mediated regulation of DNA replication—RB1—lung cancer	0.000245	0.00591	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TOP1—lung cancer	0.000242	0.00583	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—NKX2-1—lung cancer	0.000236	0.00568	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—HRAS—lung cancer	0.000236	0.00568	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—lung cancer	0.000234	0.00565	CbGpPWpGaD
Floxuridine—TYMS—Paclitaxel—Docetaxel—lung cancer	0.000233	0.0922	CbGdCrCtD
Floxuridine—TYMS—Afatinib—Gefitinib—lung cancer	0.000228	0.0902	CbGdCrCtD
Floxuridine—TYMS—Gefitinib—Erlotinib—lung cancer	0.000223	0.0884	CbGdCrCtD
Floxuridine—TYMS—G1/S Transition—PPP2R1B—lung cancer	0.000221	0.00533	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	0.00022	0.00531	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	0.000209	0.00503	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	0.000209	0.00503	CbGpPWpGaD
Floxuridine—Zidovudine—CYP2A6—lung cancer	0.000204	0.087	CrCbGaD
Floxuridine—TYMS—Nucleotide metabolism—CAT—lung cancer	0.00019	0.00458	CbGpPWpGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—PPP2R1B—lung cancer	0.000186	0.00449	CbGpPWpGaD
Floxuridine—Zidovudine—ABCG2—lung cancer	0.000182	0.0779	CrCbGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	0.000163	0.00391	CbGpPWpGaD
Floxuridine—TYMS—Vincristine—Vinorelbine—lung cancer	0.00016	0.0634	CbGdCrCtD
Floxuridine—TYMS—Circadian rythm related genes—AHR—lung cancer	0.000156	0.00376	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—COL4A3BP—lung cancer	0.000156	0.00375	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AZIN2—lung cancer	0.000156	0.00375	CbGpPWpGaD
Floxuridine—TYMS—Vinorelbine—Vinblastine—lung cancer	0.000149	0.0592	CbGdCrCtD
Floxuridine—TYMS—Podofilox—Etoposide—lung cancer	0.000149	0.0592	CbGdCrCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	0.000142	0.00342	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—ADCY1—lung cancer	0.000139	0.00335	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ATP5H—lung cancer	0.000132	0.00319	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CREBBP—lung cancer	0.00013	0.00314	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—RB1—lung cancer	0.00013	0.00313	CbGpPWpGaD
Floxuridine—TYMS—Vinblastine—Vinorelbine—lung cancer	0.000129	0.0509	CbGdCrCtD
Floxuridine—Cladribine—ABCG2—lung cancer	0.000128	0.0549	CrCbGaD
Floxuridine—TYMS—Vincristine—Vinblastine—lung cancer	0.000128	0.0506	CbGdCrCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000127	0.00305	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.00012	0.00289	CbGpPWpGaD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—lung cancer	0.00012	0.00289	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PLBD1—lung cancer	0.000118	0.00284	CbGpPWpGaD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—lung cancer	0.000114	0.00275	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000114	0.00274	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RB1—lung cancer	0.000113	0.00272	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HSD17B10—lung cancer	0.000108	0.0026	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000103	0.00249	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CKB—lung cancer	0.0001	0.00241	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	9.63e-05	0.00232	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	9.59e-05	0.00231	CbGpPWpGaD
Floxuridine—TYMS—G1/S Transition—RB1—lung cancer	9.43e-05	0.00227	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CNDP2—lung cancer	9.42e-05	0.00227	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTM2—lung cancer	9.42e-05	0.00227	CbGpPWpGaD
Floxuridine—Hypersensitivity—Vinblastine—lung cancer	9.38e-05	0.00111	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN1A—lung cancer	9.33e-05	0.00225	CbGpPWpGaD
Floxuridine—Muscle spasms—Cisplatin—lung cancer	9.33e-05	0.00111	CcSEcCtD
Floxuridine—Leukopenia—Gemcitabine—lung cancer	9.32e-05	0.00111	CcSEcCtD
Floxuridine—Stomatitis—Docetaxel—lung cancer	9.22e-05	0.00109	CcSEcCtD
Floxuridine—Decreased appetite—Vinorelbine—lung cancer	9.2e-05	0.00109	CcSEcCtD
Floxuridine—TYMP—Metabolism—MTMR3—lung cancer	9.17e-05	0.00221	CbGpPWpGaD
Floxuridine—Asthenia—Vinblastine—lung cancer	9.13e-05	0.00108	CcSEcCtD
Floxuridine—Hypersensitivity—Topotecan—lung cancer	9.11e-05	0.00108	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	9.04e-05	0.00218	CbGpPWpGaD
Floxuridine—Alopecia—Etoposide—lung cancer	9.03e-05	0.00107	CcSEcCtD
Floxuridine—Lethargy—Methotrexate—lung cancer	9.03e-05	0.00107	CcSEcCtD
Floxuridine—Ill-defined disorder—Cisplatin—lung cancer	9.01e-05	0.00107	CcSEcCtD
Floxuridine—Discomfort—Irinotecan—lung cancer	8.99e-05	0.00107	CcSEcCtD
Floxuridine—Anaemia—Cisplatin—lung cancer	8.97e-05	0.00106	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—AVP—lung cancer	8.96e-05	0.00216	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PGAM1—lung cancer	8.93e-05	0.00215	CbGpPWpGaD
Floxuridine—Epistaxis—Docetaxel—lung cancer	8.92e-05	0.00106	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—EP300—lung cancer	8.88e-05	0.00214	CbGpPWpGaD
Floxuridine—Asthenia—Topotecan—lung cancer	8.87e-05	0.00105	CcSEcCtD
Floxuridine—Alopecia—Paclitaxel—lung cancer	8.85e-05	0.00105	CcSEcCtD
Floxuridine—Thrombophlebitis—Doxorubicin—lung cancer	8.85e-05	0.00105	CcSEcCtD
Floxuridine—Agranulocytosis—Docetaxel—lung cancer	8.82e-05	0.00105	CcSEcCtD
Floxuridine—Confusional state—Irinotecan—lung cancer	8.8e-05	0.00104	CcSEcCtD
Floxuridine—Asthenia—Erlotinib—lung cancer	8.78e-05	0.00104	CcSEcCtD
Floxuridine—Discomfort—Gemcitabine—lung cancer	8.76e-05	0.00104	CcSEcCtD
Floxuridine—Malaise—Cisplatin—lung cancer	8.75e-05	0.00104	CcSEcCtD
Floxuridine—Anaphylactic shock—Irinotecan—lung cancer	8.72e-05	0.00104	CcSEcCtD
Floxuridine—Photosensitivity—Doxorubicin—lung cancer	8.72e-05	0.00104	CcSEcCtD
Floxuridine—Erythema—Paclitaxel—lung cancer	8.72e-05	0.00103	CcSEcCtD
Floxuridine—Feeling abnormal—Vinorelbine—lung cancer	8.72e-05	0.00103	CcSEcCtD
Floxuridine—Diarrhoea—Vinblastine—lung cancer	8.71e-05	0.00103	CcSEcCtD
Floxuridine—Leukopenia—Cisplatin—lung cancer	8.69e-05	0.00103	CcSEcCtD
Floxuridine—Infection—Irinotecan—lung cancer	8.67e-05	0.00103	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vinorelbine—lung cancer	8.65e-05	0.00103	CcSEcCtD
Floxuridine—Nervous system disorder—Irinotecan—lung cancer	8.56e-05	0.00102	CcSEcCtD
Floxuridine—Muscle spasms—Etoposide—lung cancer	8.55e-05	0.00101	CcSEcCtD
Floxuridine—Thrombocytopenia—Irinotecan—lung cancer	8.54e-05	0.00101	CcSEcCtD
Floxuridine—Haemoglobin—Docetaxel—lung cancer	8.53e-05	0.00101	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP2A7—lung cancer	8.52e-05	0.00205	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Gemcitabine—lung cancer	8.5e-05	0.00101	CcSEcCtD
Floxuridine—Haemorrhage—Docetaxel—lung cancer	8.49e-05	0.00101	CcSEcCtD
Floxuridine—Diarrhoea—Topotecan—lung cancer	8.46e-05	0.001	CcSEcCtD
Floxuridine—Infection—Gemcitabine—lung cancer	8.44e-05	0.001	CcSEcCtD
Floxuridine—Pharyngitis—Docetaxel—lung cancer	8.43e-05	0.001	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	8.39e-05	0.00202	CbGpPWpGaD
Floxuridine—Muscle spasms—Paclitaxel—lung cancer	8.38e-05	0.000995	CcSEcCtD
Floxuridine—Diarrhoea—Erlotinib—lung cancer	8.37e-05	0.000994	CcSEcCtD
Floxuridine—Body temperature increased—Vinorelbine—lung cancer	8.36e-05	0.000992	CcSEcCtD
Floxuridine—Abdominal pain—Vinorelbine—lung cancer	8.36e-05	0.000992	CcSEcCtD
Floxuridine—TYMP—Metabolism—SDC4—lung cancer	8.34e-05	0.00201	CbGpPWpGaD
Floxuridine—Nervous system disorder—Gemcitabine—lung cancer	8.33e-05	0.000989	CcSEcCtD
Floxuridine—Thrombocytopenia—Gemcitabine—lung cancer	8.32e-05	0.000988	CcSEcCtD
Floxuridine—Anorexia—Irinotecan—lung cancer	8.32e-05	0.000987	CcSEcCtD
Floxuridine—Ill-defined disorder—Etoposide—lung cancer	8.25e-05	0.000979	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—FOXM1—lung cancer	8.25e-05	0.00199	CbGpPWpGaD
Floxuridine—Anaemia—Etoposide—lung cancer	8.22e-05	0.000975	CcSEcCtD
Floxuridine—Discomfort—Cisplatin—lung cancer	8.16e-05	0.000969	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	8.16e-05	0.00197	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	8.11e-05	0.00195	CbGpPWpGaD
Floxuridine—Anorexia—Gemcitabine—lung cancer	8.1e-05	0.000961	CcSEcCtD
Floxuridine—Vomiting—Vinblastine—lung cancer	8.09e-05	0.000961	CcSEcCtD
Floxuridine—Ill-defined disorder—Paclitaxel—lung cancer	8.09e-05	0.00096	CcSEcCtD
Floxuridine—Anaemia—Paclitaxel—lung cancer	8.06e-05	0.000956	CcSEcCtD
Floxuridine—Malaise—Etoposide—lung cancer	8.02e-05	0.000952	CcSEcCtD
Floxuridine—Headache—Vinblastine—lung cancer	7.97e-05	0.000946	CcSEcCtD
Floxuridine—Leukopenia—Etoposide—lung cancer	7.96e-05	0.000945	CcSEcCtD
Floxuridine—TYMS—Metabolism—COL4A3BP—lung cancer	7.96e-05	0.00192	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AZIN2—lung cancer	7.96e-05	0.00192	CbGpPWpGaD
Floxuridine—Zidovudine—ALB—lung cancer	7.95e-05	0.034	CrCbGaD
Floxuridine—TYMS—Mitotic G1-G1/S phases—RB1—lung cancer	7.94e-05	0.00191	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Cisplatin—lung cancer	7.92e-05	0.00094	CcSEcCtD
Floxuridine—Infection—Cisplatin—lung cancer	7.87e-05	0.000934	CcSEcCtD
Floxuridine—Vomiting—Topotecan—lung cancer	7.86e-05	0.000933	CcSEcCtD
Floxuridine—Malaise—Paclitaxel—lung cancer	7.86e-05	0.000933	CcSEcCtD
Floxuridine—Lethargy—Doxorubicin—lung cancer	7.82e-05	0.000927	CcSEcCtD
Floxuridine—Leukopenia—Paclitaxel—lung cancer	7.8e-05	0.000926	CcSEcCtD
Floxuridine—Rash—Topotecan—lung cancer	7.8e-05	0.000925	CcSEcCtD
Floxuridine—Hypersensitivity—Vinorelbine—lung cancer	7.79e-05	0.000925	CcSEcCtD
Floxuridine—Dermatitis—Topotecan—lung cancer	7.79e-05	0.000925	CcSEcCtD
Floxuridine—Vomiting—Erlotinib—lung cancer	7.78e-05	0.000923	CcSEcCtD
Floxuridine—Nervous system disorder—Cisplatin—lung cancer	7.77e-05	0.000922	CcSEcCtD
Floxuridine—Thrombocytopenia—Cisplatin—lung cancer	7.76e-05	0.00092	CcSEcCtD
Floxuridine—Headache—Topotecan—lung cancer	7.75e-05	0.000919	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—MYC—lung cancer	7.74e-05	0.00186	CbGpPWpGaD
Floxuridine—Rash—Erlotinib—lung cancer	7.71e-05	0.000916	CcSEcCtD
Floxuridine—Dermatitis—Erlotinib—lung cancer	7.71e-05	0.000915	CcSEcCtD
Floxuridine—Headache—Erlotinib—lung cancer	7.66e-05	0.00091	CcSEcCtD
Floxuridine—TYMP—Metabolism—RRM1—lung cancer	7.6e-05	0.00183	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA3—lung cancer	7.6e-05	0.00183	CbGpPWpGaD
Floxuridine—Asthenia—Vinorelbine—lung cancer	7.59e-05	0.000901	CcSEcCtD
Floxuridine—Zidovudine—ABCB1—lung cancer	7.59e-05	0.0324	CrCbGaD
Floxuridine—Decreased appetite—Irinotecan—lung cancer	7.58e-05	0.0009	CcSEcCtD
Floxuridine—Nausea—Vinblastine—lung cancer	7.56e-05	0.000897	CcSEcCtD
Floxuridine—Anorexia—Cisplatin—lung cancer	7.55e-05	0.000896	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	7.51e-05	0.00181	CbGpPWpGaD
Floxuridine—Alopecia—Docetaxel—lung cancer	7.5e-05	0.00089	CcSEcCtD
Floxuridine—Discomfort—Etoposide—lung cancer	7.48e-05	0.000888	CcSEcCtD
Floxuridine—Erythema—Docetaxel—lung cancer	7.39e-05	0.000877	CcSEcCtD
Floxuridine—Decreased appetite—Gemcitabine—lung cancer	7.39e-05	0.000877	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—FOXM1—lung cancer	7.37e-05	0.00178	CbGpPWpGaD
Floxuridine—Nausea—Topotecan—lung cancer	7.35e-05	0.000872	CcSEcCtD
Floxuridine—Discomfort—Paclitaxel—lung cancer	7.33e-05	0.00087	CcSEcCtD
Floxuridine—Confusional state—Etoposide—lung cancer	7.32e-05	0.000868	CcSEcCtD
Floxuridine—Nausea—Erlotinib—lung cancer	7.27e-05	0.000863	CcSEcCtD
Floxuridine—Pancytopenia—Methotrexate—lung cancer	7.26e-05	0.000862	CcSEcCtD
Floxuridine—Anaphylactic shock—Etoposide—lung cancer	7.26e-05	0.000861	CcSEcCtD
Floxuridine—Diarrhoea—Vinorelbine—lung cancer	7.24e-05	0.000859	CcSEcCtD
Floxuridine—Infection—Etoposide—lung cancer	7.21e-05	0.000856	CcSEcCtD
Floxuridine—Feeling abnormal—Irinotecan—lung cancer	7.19e-05	0.000853	CcSEcCtD
Floxuridine—Confusional state—Paclitaxel—lung cancer	7.17e-05	0.000851	CcSEcCtD
Floxuridine—TYMP—Metabolism—B4GALT5—lung cancer	7.14e-05	0.00172	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Irinotecan—lung cancer	7.13e-05	0.000847	CcSEcCtD
Floxuridine—Anaphylactic shock—Paclitaxel—lung cancer	7.12e-05	0.000844	CcSEcCtD
Floxuridine—Thrombocytopenia—Etoposide—lung cancer	7.11e-05	0.000843	CcSEcCtD
Floxuridine—Muscle spasms—Docetaxel—lung cancer	7.1e-05	0.000843	CcSEcCtD
Floxuridine—Infection—Paclitaxel—lung cancer	7.07e-05	0.000839	CcSEcCtD
Floxuridine—Dry skin—Doxorubicin—lung cancer	7.02e-05	0.000833	CcSEcCtD
Floxuridine—Feeling abnormal—Gemcitabine—lung cancer	7e-05	0.000831	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—lung cancer	6.98e-05	0.00168	CbGpPWpGaD
Floxuridine—Nervous system disorder—Paclitaxel—lung cancer	6.98e-05	0.000828	CcSEcCtD
Floxuridine—Photosensitivity reaction—Methotrexate—lung cancer	6.98e-05	0.000828	CcSEcCtD
Floxuridine—Thrombocytopenia—Paclitaxel—lung cancer	6.97e-05	0.000827	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTA4—lung cancer	6.95e-05	0.00167	CbGpPWpGaD
Floxuridine—Anorexia—Etoposide—lung cancer	6.92e-05	0.000821	CcSEcCtD
Floxuridine—Abdominal pain—Irinotecan—lung cancer	6.9e-05	0.000819	CcSEcCtD
Floxuridine—Body temperature increased—Irinotecan—lung cancer	6.9e-05	0.000819	CcSEcCtD
Floxuridine—Decreased appetite—Cisplatin—lung cancer	6.89e-05	0.000817	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—PPP2R1B—lung cancer	6.83e-05	0.00165	CbGpPWpGaD
Floxuridine—Anaemia—Docetaxel—lung cancer	6.83e-05	0.000811	CcSEcCtD
Floxuridine—Anorexia—Paclitaxel—lung cancer	6.78e-05	0.000805	CcSEcCtD
Floxuridine—Gastritis—Doxorubicin—lung cancer	6.78e-05	0.000804	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—CDKN1A—lung cancer	6.77e-05	0.00163	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTA2—lung cancer	6.77e-05	0.00163	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ATP5H—lung cancer	6.77e-05	0.00163	CbGpPWpGaD
Floxuridine—Vomiting—Vinorelbine—lung cancer	6.73e-05	0.000798	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—lung cancer	6.73e-05	0.00162	CbGpPWpGaD
Floxuridine—Body temperature increased—Gemcitabine—lung cancer	6.72e-05	0.000797	CcSEcCtD
Floxuridine—Rash—Vinorelbine—lung cancer	6.67e-05	0.000792	CcSEcCtD
Floxuridine—Dermatitis—Vinorelbine—lung cancer	6.66e-05	0.000791	CcSEcCtD
Floxuridine—Stomatitis—Methotrexate—lung cancer	6.64e-05	0.000788	CcSEcCtD
Floxuridine—Headache—Vinorelbine—lung cancer	6.63e-05	0.000787	CcSEcCtD
Floxuridine—Leukopenia—Docetaxel—lung cancer	6.61e-05	0.000785	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTA1—lung cancer	6.53e-05	0.00157	CbGpPWpGaD
Floxuridine—Feeling abnormal—Cisplatin—lung cancer	6.53e-05	0.000775	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—LMNA—lung cancer	6.52e-05	0.00157	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—lung cancer	6.52e-05	0.00157	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCC3—lung cancer	6.46e-05	0.00156	CbGpPWpGaD
Floxuridine—Angina pectoris—Doxorubicin—lung cancer	6.45e-05	0.000765	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	6.44e-05	0.00155	CbGpPWpGaD
Floxuridine—Epistaxis—Methotrexate—lung cancer	6.43e-05	0.000763	CcSEcCtD
Floxuridine—Hypersensitivity—Irinotecan—lung cancer	6.43e-05	0.000763	CcSEcCtD
Floxuridine—Agranulocytosis—Methotrexate—lung cancer	6.36e-05	0.000755	CcSEcCtD
Floxuridine—Decreased appetite—Etoposide—lung cancer	6.31e-05	0.000749	CcSEcCtD
Floxuridine—Pancytopenia—Doxorubicin—lung cancer	6.29e-05	0.000746	CcSEcCtD
Floxuridine—Nausea—Vinorelbine—lung cancer	6.28e-05	0.000746	CcSEcCtD
Floxuridine—Body temperature increased—Cisplatin—lung cancer	6.26e-05	0.000743	CcSEcCtD
Floxuridine—Asthenia—Irinotecan—lung cancer	6.26e-05	0.000743	CcSEcCtD
Floxuridine—TYMP—Metabolism—AKR1C1—lung cancer	6.26e-05	0.00151	CbGpPWpGaD
Floxuridine—Decreased appetite—Paclitaxel—lung cancer	6.19e-05	0.000734	CcSEcCtD
Floxuridine—Haemoglobin—Methotrexate—lung cancer	6.15e-05	0.00073	CcSEcCtD
Floxuridine—Haemorrhage—Methotrexate—lung cancer	6.12e-05	0.000726	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—PPP2R1B—lung cancer	6.11e-05	0.00147	CbGpPWpGaD
Floxuridine—Asthenia—Gemcitabine—lung cancer	6.1e-05	0.000724	CcSEcCtD
Floxuridine—Confusional state—Docetaxel—lung cancer	6.08e-05	0.000722	CcSEcCtD
Floxuridine—TYMP—Metabolism—UGT1A1—lung cancer	6.07e-05	0.00146	CbGpPWpGaD
Floxuridine—Pharyngitis—Methotrexate—lung cancer	6.07e-05	0.000721	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	6.07e-05	0.00146	CbGpPWpGaD
Floxuridine—Photosensitivity reaction—Doxorubicin—lung cancer	6.04e-05	0.000717	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	6.04e-05	0.00146	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Docetaxel—lung cancer	6.03e-05	0.000716	CcSEcCtD
Floxuridine—TYMS—Metabolism—PLBD1—lung cancer	6.03e-05	0.00145	CbGpPWpGaD
Floxuridine—TYMS—Azacitidine—Gemcitabine—lung cancer	6.02e-05	0.0239	CbGdCrCtD
Floxuridine—Infection—Docetaxel—lung cancer	5.99e-05	0.000711	CcSEcCtD
Floxuridine—Feeling abnormal—Etoposide—lung cancer	5.98e-05	0.00071	CcSEcCtD
Floxuridine—Diarrhoea—Irinotecan—lung cancer	5.97e-05	0.000708	CcSEcCtD
Floxuridine—Gastrointestinal pain—Etoposide—lung cancer	5.93e-05	0.000704	CcSEcCtD
Floxuridine—Nervous system disorder—Docetaxel—lung cancer	5.91e-05	0.000702	CcSEcCtD
Floxuridine—Thrombocytopenia—Docetaxel—lung cancer	5.91e-05	0.000701	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CCND1—lung cancer	5.9e-05	0.00142	CbGpPWpGaD
Floxuridine—Feeling abnormal—Paclitaxel—lung cancer	5.86e-05	0.000696	CcSEcCtD
Floxuridine—TYMP—Metabolism—GNG11—lung cancer	5.86e-05	0.00141	CbGpPWpGaD
Floxuridine—Hypersensitivity—Cisplatin—lung cancer	5.84e-05	0.000693	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—LMNA—lung cancer	5.83e-05	0.0014	CbGpPWpGaD
Floxuridine—Gastrointestinal pain—Paclitaxel—lung cancer	5.82e-05	0.000691	CcSEcCtD
Floxuridine—Diarrhoea—Gemcitabine—lung cancer	5.81e-05	0.00069	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	5.77e-05	0.00139	CbGpPWpGaD
Floxuridine—Stomatitis—Doxorubicin—lung cancer	5.75e-05	0.000683	CcSEcCtD
Floxuridine—Anorexia—Docetaxel—lung cancer	5.75e-05	0.000682	CcSEcCtD
Floxuridine—Abdominal pain—Etoposide—lung cancer	5.74e-05	0.000681	CcSEcCtD
Floxuridine—Body temperature increased—Etoposide—lung cancer	5.74e-05	0.000681	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN1A—lung cancer	5.71e-05	0.00138	CbGpPWpGaD
Floxuridine—Asthenia—Cisplatin—lung cancer	5.68e-05	0.000675	CcSEcCtD
Floxuridine—Abdominal pain—Paclitaxel—lung cancer	5.62e-05	0.000668	CcSEcCtD
Floxuridine—Body temperature increased—Paclitaxel—lung cancer	5.62e-05	0.000668	CcSEcCtD
Floxuridine—TYMS—G1/S Transition—MYC—lung cancer	5.62e-05	0.00135	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ALDOA—lung cancer	5.58e-05	0.00134	CbGpPWpGaD
Floxuridine—Epistaxis—Doxorubicin—lung cancer	5.57e-05	0.000661	CcSEcCtD
Floxuridine—Vomiting—Irinotecan—lung cancer	5.55e-05	0.000658	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—lung cancer	5.52e-05	0.00133	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HSD17B10—lung cancer	5.52e-05	0.00133	CbGpPWpGaD
Floxuridine—Agranulocytosis—Doxorubicin—lung cancer	5.51e-05	0.000654	CcSEcCtD
Floxuridine—Rash—Irinotecan—lung cancer	5.5e-05	0.000653	CcSEcCtD
Floxuridine—Dermatitis—Irinotecan—lung cancer	5.5e-05	0.000652	CcSEcCtD
Floxuridine—Headache—Irinotecan—lung cancer	5.47e-05	0.000649	CcSEcCtD
Floxuridine—Diarrhoea—Cisplatin—lung cancer	5.42e-05	0.000643	CcSEcCtD
Floxuridine—TYMP—Metabolism—NCOA3—lung cancer	5.41e-05	0.0013	CbGpPWpGaD
Floxuridine—Alopecia—Methotrexate—lung cancer	5.41e-05	0.000642	CcSEcCtD
Floxuridine—Vomiting—Gemcitabine—lung cancer	5.4e-05	0.000641	CcSEcCtD
Floxuridine—Rash—Gemcitabine—lung cancer	5.36e-05	0.000636	CcSEcCtD
Floxuridine—Dermatitis—Gemcitabine—lung cancer	5.35e-05	0.000635	CcSEcCtD
Floxuridine—Hypersensitivity—Etoposide—lung cancer	5.35e-05	0.000635	CcSEcCtD
Floxuridine—Erythema—Methotrexate—lung cancer	5.33e-05	0.000632	CcSEcCtD
Floxuridine—Haemoglobin—Doxorubicin—lung cancer	5.32e-05	0.000632	CcSEcCtD
Floxuridine—Headache—Gemcitabine—lung cancer	5.32e-05	0.000632	CcSEcCtD
Floxuridine—Haemorrhage—Doxorubicin—lung cancer	5.3e-05	0.000629	CcSEcCtD
Floxuridine—TYMP—Metabolism—ABCG2—lung cancer	5.27e-05	0.00127	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ADCY1—lung cancer	5.27e-05	0.00127	CbGpPWpGaD
Floxuridine—Pharyngitis—Doxorubicin—lung cancer	5.26e-05	0.000624	CcSEcCtD
Floxuridine—Decreased appetite—Docetaxel—lung cancer	5.24e-05	0.000622	CcSEcCtD
Floxuridine—Hypersensitivity—Paclitaxel—lung cancer	5.24e-05	0.000622	CcSEcCtD
Floxuridine—Asthenia—Etoposide—lung cancer	5.21e-05	0.000618	CcSEcCtD
Floxuridine—Nausea—Irinotecan—lung cancer	5.18e-05	0.000615	CcSEcCtD
Floxuridine—TYMP—Metabolism—ENO2—lung cancer	5.16e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—HPGDS—lung cancer	5.16e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	5.13e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PPP2R1B—lung cancer	5.13e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CKB—lung cancer	5.13e-05	0.00124	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	5.11e-05	0.00123	CbGpPWpGaD
Floxuridine—Asthenia—Paclitaxel—lung cancer	5.11e-05	0.000606	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	5.06e-05	0.00122	CbGpPWpGaD
Floxuridine—Nausea—Gemcitabine—lung cancer	5.05e-05	0.000599	CcSEcCtD
Floxuridine—Vomiting—Cisplatin—lung cancer	5.04e-05	0.000598	CcSEcCtD
Floxuridine—TYMP—Metabolism—GSTT1—lung cancer	5.01e-05	0.00121	CbGpPWpGaD
Floxuridine—Rash—Cisplatin—lung cancer	4.99e-05	0.000593	CcSEcCtD
Floxuridine—Dermatitis—Cisplatin—lung cancer	4.99e-05	0.000592	CcSEcCtD
Floxuridine—Feeling abnormal—Docetaxel—lung cancer	4.97e-05	0.00059	CcSEcCtD
Floxuridine—Diarrhoea—Etoposide—lung cancer	4.97e-05	0.000589	CcSEcCtD
Floxuridine—TYMP—Metabolism—GCLC—lung cancer	4.95e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP2A6—lung cancer	4.95e-05	0.00119	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	4.95e-05	0.00119	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Methotrexate—lung cancer	4.94e-05	0.000586	CcSEcCtD
Floxuridine—Gastrointestinal pain—Docetaxel—lung cancer	4.93e-05	0.000585	CcSEcCtD
Floxuridine—Anaemia—Methotrexate—lung cancer	4.92e-05	0.000584	CcSEcCtD
Floxuridine—Diarrhoea—Paclitaxel—lung cancer	4.87e-05	0.000578	CcSEcCtD
Floxuridine—TYMS—Metabolism—CNDP2—lung cancer	4.82e-05	0.00116	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTM2—lung cancer	4.82e-05	0.00116	CbGpPWpGaD
Floxuridine—Malaise—Methotrexate—lung cancer	4.8e-05	0.00057	CcSEcCtD
Floxuridine—Body temperature increased—Docetaxel—lung cancer	4.77e-05	0.000566	CcSEcCtD
Floxuridine—Abdominal pain—Docetaxel—lung cancer	4.77e-05	0.000566	CcSEcCtD
Floxuridine—Leukopenia—Methotrexate—lung cancer	4.77e-05	0.000566	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—MYC—lung cancer	4.73e-05	0.00114	CbGpPWpGaD
Floxuridine—Nausea—Cisplatin—lung cancer	4.71e-05	0.000558	CcSEcCtD
Floxuridine—TYMP—Metabolism—ENO1—lung cancer	4.69e-05	0.00113	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—MTMR3—lung cancer	4.69e-05	0.00113	CbGpPWpGaD
Floxuridine—Alopecia—Doxorubicin—lung cancer	4.68e-05	0.000556	CcSEcCtD
Floxuridine—Vomiting—Etoposide—lung cancer	4.61e-05	0.000548	CcSEcCtD
Floxuridine—Erythema—Doxorubicin—lung cancer	4.61e-05	0.000547	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	4.59e-05	0.00111	CbGpPWpGaD
Floxuridine—Rash—Etoposide—lung cancer	4.58e-05	0.000543	CcSEcCtD
Floxuridine—Dermatitis—Etoposide—lung cancer	4.57e-05	0.000543	CcSEcCtD
Floxuridine—TYMS—Metabolism—PGAM1—lung cancer	4.57e-05	0.0011	CbGpPWpGaD
Floxuridine—Headache—Etoposide—lung cancer	4.55e-05	0.00054	CcSEcCtD
Floxuridine—Vomiting—Paclitaxel—lung cancer	4.52e-05	0.000537	CcSEcCtD
Floxuridine—Rash—Paclitaxel—lung cancer	4.49e-05	0.000532	CcSEcCtD
Floxuridine—Dermatitis—Paclitaxel—lung cancer	4.48e-05	0.000532	CcSEcCtD
Floxuridine—Discomfort—Methotrexate—lung cancer	4.48e-05	0.000532	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	4.47e-05	0.00108	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	4.46e-05	0.00107	CbGpPWpGaD
Floxuridine—Headache—Paclitaxel—lung cancer	4.46e-05	0.000529	CcSEcCtD
Floxuridine—Hypersensitivity—Docetaxel—lung cancer	4.44e-05	0.000527	CcSEcCtD
Floxuridine—Muscle spasms—Doxorubicin—lung cancer	4.43e-05	0.000526	CcSEcCtD
Floxuridine—Confusional state—Methotrexate—lung cancer	4.38e-05	0.00052	CcSEcCtD
Floxuridine—TYMS—Metabolism—CYP2A7—lung cancer	4.36e-05	0.00105	CbGpPWpGaD
Floxuridine—Anaphylactic shock—Methotrexate—lung cancer	4.35e-05	0.000516	CcSEcCtD
Floxuridine—Asthenia—Docetaxel—lung cancer	4.33e-05	0.000514	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	4.32e-05	0.00104	CbGpPWpGaD
Floxuridine—Infection—Methotrexate—lung cancer	4.32e-05	0.000513	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	4.31e-05	0.00104	CbGpPWpGaD
Floxuridine—Nausea—Etoposide—lung cancer	4.31e-05	0.000512	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—JUN—lung cancer	4.28e-05	0.00103	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Doxorubicin—lung cancer	4.28e-05	0.000508	CcSEcCtD
Floxuridine—TYMS—Metabolism—SDC4—lung cancer	4.27e-05	0.00103	CbGpPWpGaD
Floxuridine—Nervous system disorder—Methotrexate—lung cancer	4.26e-05	0.000506	CcSEcCtD
Floxuridine—Anaemia—Doxorubicin—lung cancer	4.26e-05	0.000506	CcSEcCtD
Floxuridine—Thrombocytopenia—Methotrexate—lung cancer	4.26e-05	0.000505	CcSEcCtD
Floxuridine—Nausea—Paclitaxel—lung cancer	4.23e-05	0.000502	CcSEcCtD
Floxuridine—TYMP—Metabolism—CYP2E1—lung cancer	4.21e-05	0.00101	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—NQO1—lung cancer	4.16e-05	0.001	CbGpPWpGaD
Floxuridine—Malaise—Doxorubicin—lung cancer	4.16e-05	0.000494	CcSEcCtD
Floxuridine—Anorexia—Methotrexate—lung cancer	4.14e-05	0.000492	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—PTEN—lung cancer	4.14e-05	0.000998	CbGpPWpGaD
Floxuridine—Leukopenia—Doxorubicin—lung cancer	4.13e-05	0.00049	CcSEcCtD
Floxuridine—Diarrhoea—Docetaxel—lung cancer	4.13e-05	0.00049	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	4.11e-05	0.000991	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	4e-05	0.000964	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—EP300—lung cancer	3.95e-05	0.000952	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.9e-05	0.000939	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—RRM1—lung cancer	3.89e-05	0.000936	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA3—lung cancer	3.89e-05	0.000936	CbGpPWpGaD
Floxuridine—Discomfort—Doxorubicin—lung cancer	3.88e-05	0.00046	CcSEcCtD
Floxuridine—TYMS—Cell Cycle, Mitotic—BIRC5—lung cancer	3.86e-05	0.000931	CbGpPWpGaD
Floxuridine—Vomiting—Docetaxel—lung cancer	3.83e-05	0.000455	CcSEcCtD
Floxuridine—Rash—Docetaxel—lung cancer	3.8e-05	0.000451	CcSEcCtD
Floxuridine—Dermatitis—Docetaxel—lung cancer	3.8e-05	0.000451	CcSEcCtD
Floxuridine—Confusional state—Doxorubicin—lung cancer	3.8e-05	0.00045	CcSEcCtD
Floxuridine—Decreased appetite—Methotrexate—lung cancer	3.78e-05	0.000448	CcSEcCtD
Floxuridine—Headache—Docetaxel—lung cancer	3.78e-05	0.000448	CcSEcCtD
Floxuridine—Anaphylactic shock—Doxorubicin—lung cancer	3.76e-05	0.000447	CcSEcCtD
Floxuridine—TYMP—Metabolism—STK11—lung cancer	3.75e-05	0.000904	CbGpPWpGaD
Floxuridine—Infection—Doxorubicin—lung cancer	3.74e-05	0.000444	CcSEcCtD
Floxuridine—Nervous system disorder—Doxorubicin—lung cancer	3.69e-05	0.000438	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.69e-05	0.000888	CbGpPWpGaD
Floxuridine—Thrombocytopenia—Doxorubicin—lung cancer	3.69e-05	0.000437	CcSEcCtD
Floxuridine—TYMS—Metabolism—B4GALT5—lung cancer	3.65e-05	0.00088	CbGpPWpGaD
Floxuridine—Anorexia—Doxorubicin—lung cancer	3.59e-05	0.000426	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.59e-05	0.000864	CbGpPWpGaD
Floxuridine—Nausea—Docetaxel—lung cancer	3.58e-05	0.000425	CcSEcCtD
Floxuridine—Feeling abnormal—Methotrexate—lung cancer	3.58e-05	0.000425	CcSEcCtD
Floxuridine—Gastrointestinal pain—Methotrexate—lung cancer	3.55e-05	0.000422	CcSEcCtD
Floxuridine—TYMS—Metabolism—GSTA4—lung cancer	3.55e-05	0.000856	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3.51e-05	0.000845	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTP1—lung cancer	3.47e-05	0.000836	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA2—lung cancer	3.46e-05	0.000834	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—BIRC5—lung cancer	3.46e-05	0.000833	CbGpPWpGaD
Floxuridine—Abdominal pain—Methotrexate—lung cancer	3.44e-05	0.000408	CcSEcCtD
Floxuridine—Body temperature increased—Methotrexate—lung cancer	3.44e-05	0.000408	CcSEcCtD
Floxuridine—TYMP—Metabolism—CAT—lung cancer	3.38e-05	0.000814	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TERT—lung cancer	3.35e-05	0.000806	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTA1—lung cancer	3.34e-05	0.000805	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	3.31e-05	0.000798	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCC3—lung cancer	3.3e-05	0.000796	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ABCB1—lung cancer	3.29e-05	0.000792	CbGpPWpGaD
Floxuridine—Decreased appetite—Doxorubicin—lung cancer	3.27e-05	0.000388	CcSEcCtD
Floxuridine—TYMP—Metabolism—TYMS—lung cancer	3.23e-05	0.000778	CbGpPWpGaD
Floxuridine—Hypersensitivity—Methotrexate—lung cancer	3.2e-05	0.00038	CcSEcCtD
Floxuridine—TYMS—Metabolism—AKR1C1—lung cancer	3.2e-05	0.000771	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—GSTM1—lung cancer	3.19e-05	0.000769	CbGpPWpGaD
Floxuridine—Asthenia—Methotrexate—lung cancer	3.12e-05	0.00037	CcSEcCtD
Floxuridine—TYMS—Metabolism—UGT1A1—lung cancer	3.11e-05	0.000748	CbGpPWpGaD
Floxuridine—Feeling abnormal—Doxorubicin—lung cancer	3.1e-05	0.000368	CcSEcCtD
Floxuridine—Gastrointestinal pain—Doxorubicin—lung cancer	3.08e-05	0.000365	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	3.04e-05	0.000733	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CYP1A1—lung cancer	3.02e-05	0.000729	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ERCC2—lung cancer	3e-05	0.000723	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GNG11—lung cancer	3e-05	0.000722	CbGpPWpGaD
Floxuridine—Abdominal pain—Doxorubicin—lung cancer	2.98e-05	0.000353	CcSEcCtD
Floxuridine—Body temperature increased—Doxorubicin—lung cancer	2.98e-05	0.000353	CcSEcCtD
Floxuridine—Diarrhoea—Methotrexate—lung cancer	2.97e-05	0.000353	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.94e-05	0.000709	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—RB1—lung cancer	2.91e-05	0.000702	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ALDOA—lung cancer	2.85e-05	0.000687	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TP53—lung cancer	2.83e-05	0.000681	CbGpPWpGaD
Floxuridine—Hypersensitivity—Doxorubicin—lung cancer	2.77e-05	0.000329	CcSEcCtD
Floxuridine—TYMS—Metabolism—NCOA3—lung cancer	2.77e-05	0.000667	CbGpPWpGaD
Floxuridine—Vomiting—Methotrexate—lung cancer	2.76e-05	0.000328	CcSEcCtD
Floxuridine—Rash—Methotrexate—lung cancer	2.74e-05	0.000325	CcSEcCtD
Floxuridine—Dermatitis—Methotrexate—lung cancer	2.74e-05	0.000325	CcSEcCtD
Floxuridine—Headache—Methotrexate—lung cancer	2.72e-05	0.000323	CcSEcCtD
Floxuridine—Asthenia—Doxorubicin—lung cancer	2.7e-05	0.000321	CcSEcCtD
Floxuridine—TYMS—Metabolism—ADCY1—lung cancer	2.69e-05	0.000649	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCG2—lung cancer	2.69e-05	0.000649	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ENO2—lung cancer	2.64e-05	0.000636	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—HPGDS—lung cancer	2.64e-05	0.000636	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PPP2R1B—lung cancer	2.62e-05	0.000632	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—RB1—lung cancer	2.61e-05	0.000628	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—APOA1—lung cancer	2.59e-05	0.000625	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—IL6—lung cancer	2.59e-05	0.000623	CbGpPWpGaD
Floxuridine—Nausea—Methotrexate—lung cancer	2.58e-05	0.000306	CcSEcCtD
Floxuridine—Diarrhoea—Doxorubicin—lung cancer	2.58e-05	0.000306	CcSEcCtD
Floxuridine—TYMS—Metabolism—GSTT1—lung cancer	2.56e-05	0.000617	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—lung cancer	2.56e-05	0.000617	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GCLC—lung cancer	2.53e-05	0.00061	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP2A6—lung cancer	2.53e-05	0.00061	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.49e-05	0.000599	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ENO1—lung cancer	2.4e-05	0.000578	CbGpPWpGaD
Floxuridine—Vomiting—Doxorubicin—lung cancer	2.39e-05	0.000284	CcSEcCtD
Floxuridine—Rash—Doxorubicin—lung cancer	2.37e-05	0.000282	CcSEcCtD
Floxuridine—Dermatitis—Doxorubicin—lung cancer	2.37e-05	0.000281	CcSEcCtD
Floxuridine—TYMP—Metabolism—PIK3CG—lung cancer	2.37e-05	0.000571	CbGpPWpGaD
Floxuridine—Headache—Doxorubicin—lung cancer	2.36e-05	0.00028	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—CDKN2A—lung cancer	2.29e-05	0.000552	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—POMC—lung cancer	2.25e-05	0.000543	CbGpPWpGaD
Floxuridine—Nausea—Doxorubicin—lung cancer	2.24e-05	0.000265	CcSEcCtD
Floxuridine—TYMS—Cell Cycle—MDM2—lung cancer	2.22e-05	0.000535	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—CREBBP—lung cancer	2.2e-05	0.000529	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CCND1—lung cancer	2.16e-05	0.000521	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP2E1—lung cancer	2.15e-05	0.000519	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—NQO1—lung cancer	2.13e-05	0.000513	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN1A—lung cancer	2.09e-05	0.000504	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CD—lung cancer	2.08e-05	0.000502	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ALB—lung cancer	2.06e-05	0.000495	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—EP300—lung cancer	1.99e-05	0.00048	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CCND1—lung cancer	1.93e-05	0.000466	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—STK11—lung cancer	1.92e-05	0.000462	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN1A—lung cancer	1.87e-05	0.000451	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CB—lung cancer	1.82e-05	0.000437	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—lung cancer	1.8e-05	0.000433	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MAPK3—lung cancer	1.78e-05	0.00043	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—EP300—lung cancer	1.78e-05	0.000429	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTP1—lung cancer	1.78e-05	0.000428	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—MYC—lung cancer	1.74e-05	0.000418	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CAT—lung cancer	1.73e-05	0.000416	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ABCB1—lung cancer	1.68e-05	0.000405	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—GSTM1—lung cancer	1.63e-05	0.000393	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MAPK3—lung cancer	1.6e-05	0.000384	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTEN—lung cancer	1.57e-05	0.000378	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MYC—lung cancer	1.55e-05	0.000374	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CYP1A1—lung cancer	1.55e-05	0.000373	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ERCC2—lung cancer	1.53e-05	0.00037	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—EP300—lung cancer	1.5e-05	0.00036	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—APOA1—lung cancer	1.33e-05	0.00032	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—lung cancer	1.27e-05	0.000307	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CG—lung cancer	1.21e-05	0.000292	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—POMC—lung cancer	1.15e-05	0.000278	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CREBBP—lung cancer	1.12e-05	0.000271	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PIK3CA—lung cancer	1.11e-05	0.000267	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CD—lung cancer	1.07e-05	0.000257	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ALB—lung cancer	1.05e-05	0.000253	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CB—lung cancer	9.29e-06	0.000224	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—lung cancer	9.2e-06	0.000222	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—AKT1—lung cancer	9.04e-06	0.000218	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTEN—lung cancer	8.02e-06	0.000193	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—EP300—lung cancer	7.65e-06	0.000184	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PIK3CA—lung cancer	5.66e-06	0.000136	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—AKT1—lung cancer	4.62e-06	0.000111	CbGpPWpGaD
